Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain
  • Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Germany Poland Romania Slovakia Spain
  • Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

    Recruiting

    2 1
    Investigated Diseases:
    Denmark
  • Safety and Tolerability of Intrathecal TRCN-1023 in Adults with Amyotrophic Lateral Sclerosis (ALS) – Randomized Placebo‑Controlled Phase 1/2 Trial

    Recruiting

    1 1
    Investigated Diseases:
    Germany The Netherlands
  • A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    France Germany Greece Italy The Netherlands Poland
  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on the Safety and Effectiveness of ATTR-01 for Adults with Certain Types of Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

    Recruiting

    3 1
    Investigated Drugs:
    France Germany Greece Hungary Italy The Netherlands +2
  • Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

    Recruiting

    3 1 1 1
    Belgium France Germany Hungary Italy The Netherlands +2